Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19
Scientists at Oxford-based pharmatech company Exscientia are hoping to find a drug against COVID-19 within a year, using artificial intelligence technology.
In mid-March, they received a set of 12,000 de-risked drugs (drug molecules and molecules that have been checked for human safety) from the Calibr Institute based in California.
The lab has selected four different viral targets, which are proteins from the SARS-CoV-2 and are checking if they are affecting the molecules.
Scientific coordinator Aude Echalier says that it is essential to consider the "small molecule drug route" as a vaccine may never be found.
(Source: AFP)
Children risk 'generational catastrophe' from COVID: Watchdog
WHO in ‘imminent danger’ due to funding shortage: Top expert
‘New strain of coronavirus may have leaked from UK vaccine lab’
VIDEO | Karachi sit-in amplifies nationwide call for justice for Parachinar victims
Iran strongly condemns Israeli bombing of Yemen's civilian infrastructure
VIDEO | Press TV's news headlines
VIDEO | Israel and Iran’s Nuclear Facilities?
At least three killed as Israel bombs Sana'a airport, power plant
Palestinian children freeze to death amid Israeli carnage in Gaza
Houthi: Yemen’s hypersonic missiles have surprised enemy
Israel makes deepened incursion into Lebanon despite truce
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
